Taysha Gene Therapies, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 AKRO
|
Akero Therapeutics, Inc. | $28.69 | $1.59 B | -7.1 | 61 | $0 |
 ALEC
|
Alector, Inc. | $4.67 | $420.24 M | -3.14 | 245 | $97.06 M |
 BMEA
|
Biomea Fusion, Inc. | $10.09 | $148.81 M | -1.17 | 112 | $0 |
 CABA
|
Cabaletta Bio, Inc. | $4.73 | $508.83 M | -6.16 | 136 | $0 |
 CCCC
|
C4 Therapeutics, Inc. | $5.70 | $320.64 M | -1.97 | 145 | $20.76 M |
 DAWN
|
Day One Biopharmaceuticals, Inc. | $13.91 | $1.12 B | -5.11 | 169 | $0 |
 ELYM
|
Eliem Therapeutics, Inc. | $5.09 | $258.33 M | -17.08 | 9 | $0 |
 FIXX
|
Homology Medicines, Inc. | $0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $5.29 | $243.38 M | -1.59 | 129 | $0 |
 GOSS
|
Gossamer Bio, Inc. | $0.98 | $124.06 M | -0.65 | 135 | $0 |
 HOOK
|
HOOKIPA Pharma Inc. | $4.31 | $79.07 M | -1.71 | 151 | $20.13 M |
 INZY
|
Inozyme Pharma, Inc. | $5.22 | $286.39 M | -3.43 | 59 | $0 |
 LRMR
|
Larimar Therapeutics, Inc. | $6.54 | $611.84 M | -9.99 | 42 | $0 |
 PRLD
|
Prelude Therapeutics Incorporated | $2.07 | $205.99 M | -2.02 | 128 | $0 |
 STOK
|
Stoke Therapeutics, Inc. | $12.29 | $774.50 M | -6.14 | 110 | $8.78 M |
 STTK
|
Shattuck Labs, Inc. | $3.48 | $333.81 M | -3.64 | 75 | $1.66 M |
 TERN
|
Terns Pharmaceuticals, Inc. | $8.32 | $462.44 M | -5.67 | 66 | $0 |
 XFOR
|
X4 Pharmaceuticals, Inc. | $0.67 | $169.62 M | -1.51 | 127 | $0 |